3D printing for drug manufacturing: A perspective on the future of pharmaceuticals
Journal Title: International Journal of Bioprinting - Year 2018, Vol 4, Issue 1
Abstract
Since a three-dimensional (3D) printed drug was first approved by the Food and Drug Administration in 2015, there has been a growing interest in 3D printing for drug manufacturing. There are multiple 3D printing methods – including selective laser sintering, binder deposition, stereolithography, inkjet printing, extrusion-based printing, and fused deposition modeling – which are compatible with printing drug products, in addition to both polymer filaments and hydrogels as materials for drug carriers. We see the adaptability of 3D printing as a revolutionary force in the pharmaceutical industry. Release characteristics of drugs may be controlled by complex 3D printed geometries and architectures. Precise and unique doses can be engineered and fabricated via 3D printing according to individual prescriptions. On-demand printing of drug products can be implemented for drugs with limited shelf life or for patient-specific medications, offering an alternative to traditional compounding pharmacies. For these reasons, 3D printing for drug manufacturing is the future of pharmaceuticals, making personalized medicine possible while also transforming pharmacies.
Authors and Affiliations
Eric Lepowsky and Savas Tasoglu
Keywords
Related Articles
- EP ID EP678673
- DOI -
- Views 171
- Downloads 0
3D bioprinting for tissue engineering: Stem cells in hydrogels
Surgical limitations require alternative methods of repairing and replacing diseased and damaged tissue. Regenerative medicine is a growing area of research with engineered tissues already being used successfully in pati...
High-precision three-dimensional inkjet technology for live cell bioprinting
In recent years, bioprinting has emerged as a promising technology for the construction of three-dimensional (3D) tissues to be used in regenerative medicine or in vitro screening applications. In the present study, we p...
A Perspective on Using Machine Learning in 3D Bioprinting
Recently, three-dimensional (3D) printing technologies have been widely applied in industry and our daily lives. The term 3D bioprinting has been coined to describe 3D printing at the biomedical level. Machine learning i...
Pre-clinical evaluation of advanced nerve guide conduits using a novel 3D in vitro testing model
Autografts are the current gold standard for large peripheral nerve defects in clinics despite the frequently occurring side effects like donor site morbidity. Hollow nerve guidance conduits (NGC) are proposed alternativ...
The future of skin toxicology testing – Three-dimensional bioprinting meets microfluidics
Over the years, the field of toxicology testing has evolved tremendously from the use of animal models to the adaptation of in vitro testing models. In this perspective article, we aim to bridge the gap between the regul...